# Inhalon Biopharma, Inc. — Form D

Inhalon Biopharma, Inc. of CARRBORO, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-26. The offering totals $3.6M, of which $2.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-08-26
- Form: D
- Accession: 0001822334-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $2.0M
- Remaining: $1.6M
- Investors: 13
- Date of first sale: 2020-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374195

## Issuer

- Name: Inhalon Biopharma, Inc.
- CIK: 0001822334
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 106 OAK SPRING COURT, CARRBORO, NC, 27510
- Phone: (650) 439-0110

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| John B Whelan | Director | Carrboro, NC |
| John B Whelan | Executive Officer | Carrboro, NC |
| Winnie B Wan | Director | Carrboro, NC |
| Samuel B Lai | Director | Carrboro, NC |
| Samuel B Lai | Executive Officer | Carrboro, NC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-09-17](https://search.stillhousedata.com/formd/0001822334-20-000003) | D/A | $3.6M | $2.9M |

## More

- [CIK 1822334 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822334&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001822334-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.